US Stock MarketDetailed Quotes

TRDA Entrada Therapeutics

Watchlist
  • 17.110
  • +0.130+0.77%
Close Jul 22 16:00 ET
  • 17.110
  • 0.0000.00%
Post 16:02 ET
577.62MMarket Cap24.80P/E (TTM)

Entrada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
134.05%59.12M
129.01M
41.85M
43.74M
18.17M
25.26M
0
0
0
0
Operating revenue
134.05%59.12M
--129.01M
--41.85M
--43.74M
--18.17M
--25.26M
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
22.45%38.01M
35.92%132.18M
44.43%36.94M
14.60%29.72M
46.17%34.47M
40.13%31.04M
90.21%97.25M
38.56%25.58M
80.56%25.94M
137.96%23.58M
Selling and administrative expenses
18.41%9.4M
5.39%32.29M
-12.55%8.65M
7.94%7.53M
11.39%8.17M
23.39%7.94M
101.56%30.64M
62.25%9.89M
81.20%6.98M
138.04%7.33M
-General and administrative expense
18.41%9.4M
5.39%32.29M
-12.55%8.65M
7.94%7.53M
11.39%8.17M
23.39%7.94M
101.56%30.64M
62.25%9.89M
81.20%6.98M
138.04%7.33M
Research and development costs
23.83%28.61M
49.96%99.88M
80.37%28.29M
17.05%22.19M
61.87%26.3M
46.98%23.1M
85.41%66.61M
26.88%15.69M
80.33%18.96M
137.93%16.25M
Operating profit
465.28%21.11M
96.75%-3.16M
119.18%4.91M
154.03%14.01M
30.88%-16.3M
73.91%-5.78M
-90.21%-97.25M
-38.56%-25.58M
-80.56%-25.94M
-137.96%-23.58M
Net non-operating interest income expense
58.60%4.21M
478.19%15.22M
351.79%4.29M
407.01%4.05M
946.65%4.22M
453.54%2.66M
8,590.32%2.63M
7,207.69%950K
1,310.61%799K
4,377.78%403K
Non-operating interest income
58.60%4.21M
478.19%15.22M
351.79%4.29M
407.01%4.05M
946.65%4.22M
453.54%2.66M
--2.63M
--950K
--799K
4,377.78%403K
Other net income (expense)
Income before tax
910.98%25.33M
112.74%12.06M
137.34%9.2M
171.86%18.06M
47.88%-12.08M
85.59%-3.12M
-84.95%-94.62M
-33.51%-24.63M
-74.20%-25.14M
-134.11%-23.18M
Income tax
-48.44%1.83M
18.74M
18.74M
-17.4M
13.85M
3.55M
0
0
0
0
Net income
452.05%23.5M
92.93%-6.69M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-84.95%-94.62M
-33.51%-24.63M
-74.20%-25.14M
-134.11%-23.18M
Net income continuous Operations
452.05%23.5M
92.93%-6.69M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-84.95%-94.62M
-33.51%-24.63M
-74.20%-25.14M
-134.11%-23.18M
Minority interest income
Net income attributable to the parent company
452.05%23.5M
92.93%-6.69M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-84.95%-94.62M
-33.51%-24.63M
-74.20%-25.14M
-134.11%-23.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
452.05%23.5M
92.93%-6.69M
61.25%-9.54M
241.07%35.46M
-11.86%-25.93M
69.20%-6.67M
-84.95%-94.62M
-33.51%-24.63M
-74.20%-25.14M
-134.11%-23.18M
Basic earnings per share
433.33%0.7
93.38%-0.2
63.29%-0.29
233.75%1.07
-5.41%-0.78
69.57%-0.21
62.99%-3.02
11.24%-0.79
-56.96%-0.8
-53.04%-0.74
Diluted earnings per share
423.81%0.68
93.38%-0.2
63.29%-0.29
227.50%1.02
-5.41%-0.78
69.57%-0.21
62.99%-3.02
11.24%-0.79
-56.96%-0.8
-53.04%-0.74
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 134.05%59.12M129.01M41.85M43.74M18.17M25.26M0000
Operating revenue 134.05%59.12M--129.01M--41.85M--43.74M--18.17M--25.26M--0--0--0--0
Cost of revenue
Gross profit
Operating expense 22.45%38.01M35.92%132.18M44.43%36.94M14.60%29.72M46.17%34.47M40.13%31.04M90.21%97.25M38.56%25.58M80.56%25.94M137.96%23.58M
Selling and administrative expenses 18.41%9.4M5.39%32.29M-12.55%8.65M7.94%7.53M11.39%8.17M23.39%7.94M101.56%30.64M62.25%9.89M81.20%6.98M138.04%7.33M
-General and administrative expense 18.41%9.4M5.39%32.29M-12.55%8.65M7.94%7.53M11.39%8.17M23.39%7.94M101.56%30.64M62.25%9.89M81.20%6.98M138.04%7.33M
Research and development costs 23.83%28.61M49.96%99.88M80.37%28.29M17.05%22.19M61.87%26.3M46.98%23.1M85.41%66.61M26.88%15.69M80.33%18.96M137.93%16.25M
Operating profit 465.28%21.11M96.75%-3.16M119.18%4.91M154.03%14.01M30.88%-16.3M73.91%-5.78M-90.21%-97.25M-38.56%-25.58M-80.56%-25.94M-137.96%-23.58M
Net non-operating interest income expense 58.60%4.21M478.19%15.22M351.79%4.29M407.01%4.05M946.65%4.22M453.54%2.66M8,590.32%2.63M7,207.69%950K1,310.61%799K4,377.78%403K
Non-operating interest income 58.60%4.21M478.19%15.22M351.79%4.29M407.01%4.05M946.65%4.22M453.54%2.66M--2.63M--950K--799K4,377.78%403K
Other net income (expense)
Income before tax 910.98%25.33M112.74%12.06M137.34%9.2M171.86%18.06M47.88%-12.08M85.59%-3.12M-84.95%-94.62M-33.51%-24.63M-74.20%-25.14M-134.11%-23.18M
Income tax -48.44%1.83M18.74M18.74M-17.4M13.85M3.55M0000
Net income 452.05%23.5M92.93%-6.69M61.25%-9.54M241.07%35.46M-11.86%-25.93M69.20%-6.67M-84.95%-94.62M-33.51%-24.63M-74.20%-25.14M-134.11%-23.18M
Net income continuous Operations 452.05%23.5M92.93%-6.69M61.25%-9.54M241.07%35.46M-11.86%-25.93M69.20%-6.67M-84.95%-94.62M-33.51%-24.63M-74.20%-25.14M-134.11%-23.18M
Minority interest income
Net income attributable to the parent company 452.05%23.5M92.93%-6.69M61.25%-9.54M241.07%35.46M-11.86%-25.93M69.20%-6.67M-84.95%-94.62M-33.51%-24.63M-74.20%-25.14M-134.11%-23.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 452.05%23.5M92.93%-6.69M61.25%-9.54M241.07%35.46M-11.86%-25.93M69.20%-6.67M-84.95%-94.62M-33.51%-24.63M-74.20%-25.14M-134.11%-23.18M
Basic earnings per share 433.33%0.793.38%-0.263.29%-0.29233.75%1.07-5.41%-0.7869.57%-0.2162.99%-3.0211.24%-0.79-56.96%-0.8-53.04%-0.74
Diluted earnings per share 423.81%0.6893.38%-0.263.29%-0.29227.50%1.02-5.41%-0.7869.57%-0.2162.99%-3.0211.24%-0.79-56.96%-0.8-53.04%-0.74
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg